SCHEMBL521956

SCHEMBL521956

CCCOc1ccc2cc3ccccc3cc2c1OCCC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TLR8 Q9NR97 2/20 0.44
CNR1 P21554 1/20 0.43
CNR2 P34972 1/20 0.43
GAA P10253 2/20 0.42
TDP1 Q9NUW8 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
TSHR P16473 2/20 0.42
NQO1 P15559 1/20 0.42
MCHR1 Q99705 1/20 0.41
GPBAR1 Q8TDU6 1/20 0.40
CYSLTR1 Q9Y271 1/20 0.40
KDM4E B2RXH2 3/20 0.39
ALDH1A1 P00352 3/20 0.39
POLB P06746 2/20 0.39
HTT P42858 2/20 0.39
USP2 O75604 1/20 0.39
TP53 P04637 1/20 0.39
MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27740256 0.95 GAA (0.49) TLR8CNR1CNR2GAATDP1
SCHEMBL520954 0.92 GAA (0.51) TLR8CNR1CNR2GAATDP1
SCHEMBL23529417 0.91 TLR8 (0.47) TLR8CNR1CNR2GAATDP1
SCHEMBL27599502 0.91 GAA (0.50) TLR8CNR1CNR2GAATDP1
SCHEMBL27924031 0.89 TLR8 (0.48) TLR8CNR1CNR2GAATDP1
SCHEMBL28235946 0.89 TLR8 (0.48) TLR8CNR1CNR2GAATDP1
SCHEMBL27760706 0.87 TLR8 (0.40) TLR8CNR1CNR2GAATDP1
SCHEMBL27800237 0.86 TDP1 (0.49) TLR8CNR1CNR2GAATDP1
SCHEMBL27803631 0.86 TDP1 (0.46) TLR8CNR1CNR2GAATDP1
SCHEMBL28253133 0.86 NCF1 (0.47) GAATDP1L3MBTL1NQO1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10442941-B2 Curable compositions BLUE CUBE IP LLC (US) 2019-10-15 US claimed
US-20180072900-A1 CURABLE COMPOSITIONS DOW GLOBAL TECHNOLOGIES LLC 2018-03-15 US claimed
EP-3271429-A1 CURABLE COMPOSITIONS Blue Cube IP LLC (US) 2018-01-24 EP claimed
WO-2016160346-A1 CURABLE COMPOSITIONS BLUE CUBE IP LLC (US) 2016-10-06 WO claimed
US-20260062548-A1 RUBBER-BONDED CELLULOSE FIBERS AND MANUFACTURING METHOD THEREFOR, RESIN COMPOSITION AND MANUFACTURING METHOD THEREFOR, AND CURABLE RESIN COMPOSITION KUREHA CORPORATION (JP) 2026-03-05 US disclosed
EP-4582459-A1 RUBBER-BONDED CELLULOSE FIBERS AND MANUFACTURING METHOD THEREFOR, RESIN COMPOSITION AND MANUFACTURING METHOD THEREFOR, AND CURABLE RESIN COMPOSITION Kureha Corporation (JP) 2025-07-09 EP disclosed
CN-119768439-A Rubber-bonded cellulose fiber, method for producing same, resin composition, method for producing same, and cured resin composition 株式会社吴羽 2025-04-04 CN disclosed
CN-118900866-A Curable resin composition 太阳控股株式会社 2024-11-05 CN disclosed
EP-4388020-A1 POLYMER, PHOTOSENSITIVE RESIN COMPOSITION, PHOTOSENSITIVE ELEMENT, METHOD FOR FORMING RESIST PATTERN, AND METHOD FOR FORMING WIRING PATTERN Resonac Corporation (JP) 2024-06-26 EP disclosed
WO-2024057730-A1 ORGANIC EL DISPLAY DEVICE 東レ株式会社 2024-03-21 WO disclosed
WO-2024048585-A1 RUBBER-BONDED CELLULOSE FIBERS AND MANUFACTURING METHOD THEREFOR, RESIN COMPOSITION AND MANUFACTURING METHOD THEREFOR, AND CURABLE RESIN COMPOSITION 株式会社クレハ 2024-03-07 WO disclosed
WO-2023182495-A1 CURABLE RESIN COMPOSITION 太陽ホールディングス株式会社 2023-09-28 WO disclosed
CN-1301239-C Process for producing anthracene diether KAWASAKI KASEI CHEMICALS (JP) 2007-02-21 CN disclosed
EP-1735152-A1 METHOD OF MANUFACTURING LOW-ODOR PACKAGING MATERIALS Sun Chemical Corporation (US) 2006-12-27 EP disclosed
US-20060079721-A1 Process for producing anthracene diether HIROYUKI HONDA ET EL 2006-04-13 US disclosed
CN-1714065-A Process for producing anthracene diether KAWASAKI KASEI CHEMICALS (JP) 2005-12-28 CN disclosed
WO-2005097495-A1 METHOD OF MANUFACTURING LOW-ODOR PACKAGING MATERIALS SUN CHEMICAL CORPORATION (US) 2005-10-20 WO disclosed
EP-1574493-A1 PROCESS FOR PRODUCING ANTHRACENE DIETHER Kawasaki Kasei Chemicals Ltd. (JP) 2005-09-14 EP disclosed
WO-2005071027-A1 HYBRID ENERGY CURABLE SOLVENT-BASED LIQUID PRINTING INKS SUN CHEMICAL CORPORATION (US) 2005-08-04 WO disclosed
EP-0927726-B1 PHOTOCATALYTIC COMPOSITION NIPPON SODA CO (JP) 2004-11-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060079721-A1 Process for producing anthracene diether DOHH, DHCR7, HSD17B11 TLR8 3124/4885CNR1 4216/4885CNR2 4321/4885
US-20260062548-A1 RUBBER-BONDED CELLULOSE FIBERS AND MANUFACTURING METHOD THEREFOR, RESIN COMPOSITION AND MANUFACTURING METHOD THEREFOR, AND CURABLE RESIN COMPOSITION CROCC, WASF2, DCXR TLR8 3289/4885CNR1 2337/4885CNR2 3078/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.